1. Pei, Xuelian, Li, Muhan, Zhan, Jun, He, Huiying, Zhang, Hongquan. 2015. Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression. In PloS one, 10, e0124338. doi:10.1371/journal.pone.0124338. https://pubmed.ncbi.nlm.nih.gov/25919292/
2. Huang, Q-D, Zheng, S-R, Cai, Y-J, Shi, H, Guo, G-L. . IMP3 promotes TNBC stem cell property through miRNA-34a regulation. In European review for medical and pharmacological sciences, 22, 2688-2696. doi:10.26355/eurrev_201805_14965. https://pubmed.ncbi.nlm.nih.gov/29771420/
3. Su, Peng, Hu, Jing, Zhang, Hui, Xiang, Lei, Zhou, Gengyin. 2014. IMP3 expression is associated with epithelial-mesenchymal transition in breast cancer. In International journal of clinical and experimental pathology, 7, 3008-17. doi:. https://pubmed.ncbi.nlm.nih.gov/25031719/
4. Zhang, Xiang, Wang, Dawei, Liu, Boke, Tu, Weichao, Shao, Yuan. 2020. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way. In Journal of experimental & clinical cancer research : CR, 39, 190. doi:10.1186/s13046-020-01657-0. https://pubmed.ncbi.nlm.nih.gov/32938489/
5. Jønson, Lars, Christiansen, Jan, Hansen, Thomas V O, Yamamoto, Yohei, Nielsen, Finn C. 2014. IMP3 RNP safe houses prevent miRNA-directed HMGA2 mRNA decay in cancer and development. In Cell reports, 7, 539-551. doi:10.1016/j.celrep.2014.03.015. https://pubmed.ncbi.nlm.nih.gov/24703842/
智鼠故事 
